SCL vs. NGVT, CDE, AG, ANDE, IAG, ERO, WS, SAND, MTRN, and FSM
Should you be buying Stepan stock or one of its competitors? The main competitors of Stepan include Ingevity (NGVT), Coeur Mining (CDE), First Majestic Silver (AG), Andersons (ANDE), IAMGOLD (IAG), Ero Copper (ERO), Worthington Steel (WS), Sandstorm Gold (SAND), Materion (MTRN), and Fortuna Silver Mines (FSM). These companies are all part of the "basic materials" sector.
Stepan (NYSE:SCL) and Ingevity (NYSE:NGVT) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation.
Stepan has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Stepan, indicating that it is currently the more affordable of the two stocks.
Ingevity received 132 more outperform votes than Stepan when rated by MarketBeat users. Likewise, 65.39% of users gave Ingevity an outperform vote while only 55.45% of users gave Stepan an outperform vote.
In the previous week, Stepan had 5 more articles in the media than Ingevity. MarketBeat recorded 7 mentions for Stepan and 2 mentions for Ingevity. Ingevity's average media sentiment score of 1.26 beat Stepan's score of 0.22 indicating that Ingevity is being referred to more favorably in the news media.
Stepan has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Ingevity has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500.
Stepan presently has a consensus price target of $89.00, indicating a potential upside of 1.07%. Ingevity has a consensus price target of $55.00, indicating a potential upside of 2.71%. Given Ingevity's higher probable upside, analysts plainly believe Ingevity is more favorable than Stepan.
Stepan has a net margin of 1.71% compared to Ingevity's net margin of -6.84%. Ingevity's return on equity of 18.65% beat Stepan's return on equity.
82.7% of Stepan shares are held by institutional investors. Comparatively, 91.6% of Ingevity shares are held by institutional investors. 6.9% of Stepan shares are held by company insiders. Comparatively, 1.1% of Ingevity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
Ingevity beats Stepan on 10 of the 18 factors compared between the two stocks.
Get Stepan News Delivered to You Automatically
Sign up to receive the latest news and ratings for SCL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SCL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
